U.S. drugmaker Perrigo agreed Monday to buy Ireland's Elan for $8.6 billion in a deal that should allow the rapidly growing company to reduce its tax bill and boost its royalty stream.
Jul 29, 2013
0
0
Despite economic crises and dwindling aid, the UN said Monday huge progress had been made towards meeting the so-called Millennium Development Goals, including its bid to slash world hunger in half between 1990 and 2015.
Jul 1, 2013
0
0
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
Jun 18, 2013
0
0
Apricus Biosciences Inc. said Monday that its impotence drug Vitaros has been approved in 10 European countries.
Jun 10, 2013
0
0
Suppose you had $1,000 to invest in the stock market. How would you decide to pick one stock over another? Scientists have made great progress in understanding the neuroscience behind how people choose between similar options.
Apr 19, 2013
0
0
(HealthDay)—A substantially high number of patients undergoing spinal fusion have a vitamin D deficiency or inadequacy, according to a study published in the March 15 issue of Spine.
Mar 28, 2013
0
0
(AP)—Shares of respiratory drug maker KaloBios Pharmaceuticals are inching higher on the first day of trading.
Feb 1, 2013
0
0
Pfizer Inc.'s fourth-quarter profit more than quadrupled, despite competition from generic drugs hurting sales of Lipitor and other medicines, because of a $4.8 billion gain from selling its nutrition business. The drugmaker's ...
Jan 29, 2013
0
0
Swiss pharmaceutical group Roche said Tuesday the US Federal Trade Commission had requested additional information on its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina.
Mar 13, 2012
0
0
India's largest biotechnology firm, Biocon, and US pharmaceutical giant Pfizer said Tuesday they would scrap a joint plan to sell insulin products, sending Biocon's shares plunging.
Mar 13, 2012
0
0
